WHO ICTRP trial
EFFICACY AND SAFETY OF ZOFENOPRIL+HYDROCHLOROTHIAZIDE COMBINATION VS…
EUCTR2009-012993-10-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-012993-10-IT |
|---|---|
| Public title | EFFICACY AND SAFETY OF ZOFENOPRIL+HYDROCHLOROTHIAZIDE COMBINATION VS. IRBESARTAN+HYDROCHLOROTHIAZIDE COMBINATION IN METABOLIC SYNDROME PATIENTS WITH ESSENTIAL HYPERTENSION NOT CONTROLLED BY PREVIOUS MONOTHERAPY - MEN/09/ZOF-IPE/001 |
| Scientific title | EFFICACY AND SAFETY OF ZOFENOPRIL+HYDROCHLOROTHIAZIDE COMBINATION VS. IRBESARTAN+HYDROCHLOROTHIAZIDE COMBINATION IN METABOLIC SYNDROME PATIENTS WITH ESSENTIAL HYPERTENSION NOT CONTROLLED BY PREVIOUS MONOTHERAPY - MEN/09/ZOF-IPE/001 |
| Primary sponsor | A. MENARINI I.F.R. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | PATIENTS affected by METABOLIC SYNDROME WITH ESSENTIAL HYPERTENSION NOT CONTROLLED BY PREVIOUS MONOTHERAPY MedDRA version: 9.1 Level: LLT Classification code 10052066 |
| Interventions | Pharmaceutical Form: Capsule, hard INN or Proposed INN: Zofenopril and diuretics Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 42.5- Pharmaceutical Form: Capsule, hard INN or Proposed INN: Zofenopril… |
| Registration date | Jul 8, 2009 |
| Target size | 482 |
| Secondary IDs | MEN/09/ZOF-IPE/001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: